Banner Health

OrganizationROROpenAlex

People

Sources: reporter.nih.gov, openalex.org

Trials

  • NCT07727473

    Early phase 1, Not yet recruiting, 20 people, Jul 27, 2026

  • NCT06996730

    Phase 2/3, Recruiting, 240 people, May 30, 2025

  • NCT01094340

    Phase 2/3, Status unknown, 20 people, Mar 26, 2010

Grants and prizes

  • National Institute on Aging

    R01, Alzheimer's Prevention Initiative ADAD Colombia Trial Program, R01AG086363, $351K, 2024–2029, Sep 3, 2026

  • National Institute on Aging

    P30, Arizona Alzheimer's Disease Research Center, P30AG072980, $4.6M, 2021–2031, Aug 31, 2026

  • National Institute on Aging

    R01, Tracer harmonization for amyloid and tau PET imaging using statistical and deep learning techniques, R01AG073424, $708K, 2022–2027, Jul 8, 2026

  • University of Utah

    Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pa (sub-award to BANNER HEALTH), usaspending_subaward/ASST_NON_R01AG096179_075/SB35ENJFKK14, $4.6M, 2026, Feb 3, 2026

  • Arizona State University

    Developing a performance-based measure of daily function for screening Hispanic/Latino older adults (sub-award to BANNER HEALTH), usaspending_subaward/ASST_NON_RF1AG091339_075/SB35ENJFKK14, $62.2K, 2025, Dec 31, 2025

  • National Institute on Aging

    R33, Optimizing Research Infrastructure of Registries to Accelerate Participant Recruitment into Alzheimer's Focused Studies, R33AG070604, $759K, 2021–2027, Aug 13, 2025

  • Alzheimer's Drug Discovery Foundation

    Diagnostics Accelerator, Determining %p-tau217 and MTBR-243 by immunoassay, ADDF-22806630, $322K, 2025–2027, Apr 1, 2025

  • National Institute on Aging

    R01, APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease, R01AG069453, $4.9M, 2020–2027, Apr 1, 2025

  • National Institute on Aging

    R01, API A4 Alzheimer's Prevention Trial, R01AG058468, $4.1M, 2018–2025, Mar 11, 2025

  • National Institute on Aging

    R03, Cardiovascular Genotype and APOE ε4 Carrier Status Interaction Effects on Amyloid Load in Pre-Clinical Alzheimer's Disease, R03AG077270, $89.4K, 2023–2026, Mar 4, 2024

  • National Institute on Aging

    R01, Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials, R01AG063954, $1.8M, 2019–2026, Jul 14, 2023

  • National Institute on Aging

    R01, Alzheimer's Prevention Initiative ADAD Colombia Trial, R01AG055444, $5.8M, 2017–2024, Apr 28, 2022

  • BrightFocus Foundation

    Alzheimer's Disease Research: Standard, Blood Brain Barrier and Metabolism in Aging and AD, A2017272S, $300K, 2017–2021, Jul 1, 2017

Sources: reporter.nih.gov, openalex.org

Named in competing interests

Sources: europepmc.org, pubmed.ncbi.nlm.nih.gov

Papers